|
業務類別
|
Diagnostics & Research |
|
業務概覽
|
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. |
| 公司地址
| 5200 Illumina Way, San Diego, CA, USA, 92122 |
| 電話號碼
| +1 858 202-4500 |
| 傳真號碼
| +1 858 202-4545 |
| 公司網頁
| https://www.illumina.com |
| 員工數量
| 10080 |
| Ms. Patricia Leckman |
Chief People Officer |
-- |
09/04/2026 |
| Mr. Scott M. Davies |
Chief Legal Officer |
-- |
09/04/2026 |
| Mr. Ankur Dhingra |
Chief Financial Officer |
美元 650.00K |
09/04/2026 |
| Mr. Scott Ericksen |
Vice President and Chief Accounting Officer |
-- |
12/02/2026 |
| Dr. Steve Barnard, PhD |
Chief Technology Officer |
美元 600.00K |
09/04/2026 |
| Mr. Christensen Jakob Wedel |
Chief Strategy and Corporate Development Officer |
-- |
09/04/2026 |
| Mr. Jacob Thaysen |
Director and Chief Executive Officer |
美元 1.00M |
09/04/2026 |
| Mr. Kevin Carl Pegels |
Chief, Global Operations |
美元 575.00K |
09/04/2026 |
|
|
| Ms. Caroline D. Dorsa |
Independent Director |
09/04/2026 |
| Ms. Anna S. Richo |
Independent Director |
09/04/2026 |
| Mr. David P King |
Independent Director |
09/04/2026 |
| Dr. Gary S. Guthart,PhD |
Independent Director |
02/04/2026 |
| Mr. Philip W. Schiller |
Independent Director |
09/04/2026 |
| Ms. Susan E. Siegel |
Independent Director |
09/04/2026 |
| Dr. Robert S. Epstein, M.D.,M.S. |
Independent Director |
02/04/2026 |
| Dr. Scott Gottlieb,M.D. |
Chairman of the board |
09/04/2026 |
| Dr. Frances H. Arnold, PhD |
Independent Director |
02/04/2026 |
| Mr. Scott B. Ullem |
Independent Director |
09/04/2026 |
| Mr. Keith A. Meister |
Independent Director |
09/04/2026 |
| Mr. Jacob Thaysen |
Director and Chief Executive Officer |
09/04/2026 |
|
|
|
|
